FIELD: medicine; pharmacology.
SUBSTANCE: combined preparation includes an inhibitor of repeated absorption of the serotonin, representing fluoxetine, and the antagonist of a 5NT1a-receptor chosen from group, which make N-[2[4(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinilcyclohexancarboxamide and (R)-N-(2-methyl-(4-indolil-1-piperazinyl)ethyl)-N-(2-pyridinil) cyclohexancarboxamide, in therapeutically effective amounts.
EFFECT: treatment of thermoregulation function disorders at patients that cannot be exposed to ways of medical influence on the basis of steroids.
2 cl, 5 ex, 5 dwg
